Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The present protocol describes light-sheet fluorescent microscopy and automated software-assisted methods to visualize and precisely quantify proliferating and dormant Trypanosoma cruzi parasites and T cells in intact, cleared organs and tissues. These techniques provide a reliable way to evaluate treatment outcomes and offer new insights into parasite-host interactions.

Abstract

Chagas disease is a neglected pathology that affects millions of people worldwide, mainly in Latin America. The Chagas disease agent, Trypanosoma cruzi (T. cruzi), is an obligate intracellular parasite with a diverse biology that infects several mammalian species, including humans, causing cardiac and digestive pathologies. Reliable detection of T. cruzi in vivo infections has long been needed to understand Chagas disease's complex biology and accurately evaluate the outcome of treatment regimens. The current protocol demonstrates an integrated pipeline for automated quantification of T. cruzi-infected cells in 3D-reconstructed, cleared organs. Light-sheet fluorescent microscopy allows for accurately visualizing and quantifying of actively proliferating and dormant T. cruzi parasites and immune effector cells in whole organs or tissues. Also, the CUBIC-HistoVision pipeline to obtain uniform labeling of cleared organs with antibodies and nuclear stains was successfully adopted. Tissue clearing coupled with 3D immunostaining provides an unbiased approach to comprehensively evaluate drug treatment protocols, improve the understanding of the cellular organization of T. cruzi-infected tissues, and is expected to advance discoveries related to anti-T. cruzi immune responses, tissue damage, and repair in Chagas disease.

Introduction

Chagas disease, caused by the protozoan parasite T. cruzi, is among the world's most neglected tropical diseases, causing approximately 13,000 annual deaths. The infection often progresses from an acute to a chronic stage producing cardiac pathology in 30% of the patients, including arrhythmias, heart failure, and sudden death1,2. Despite the strong host immune response elicited against the parasite during the acute phase, low numbers of parasites chronically persist throughout the host's life in tissues such as the heart and skeletal muscle. Several factors, including the delayed onset of ada....

Protocol

This study was carried out in strict accordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals and Association for Assessment and Accreditation of Laboratory Animal Care accreditation guidelines. The Animal Use Protocol (control of T. cruzi infection in mice-A2021 04-011-Y1-A0) was approved by the University of Georgia Institutional Animal Care and Use Committee. B6.C+A2:A44g-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J.......

Representative Results

CUBIC fixed tissues were washed with PBS to remove fixatives and then incubated with CUBIC-L cocktails, a basic buffered solution of amino alcohols that extract pigments and lipids from the tissue resulting in decolorization of tissue while maintaining tissue architecture. Grid lines in the paper can be seen through the tissues indicating an appropriate clearing of the organs (Figure 2A). After delipidation, tissues were washed and immersed in CUBIC-R+ and mounting solution .......

Discussion

The absence of extensive, whole-organ imaging of parasites and the immune response limits the understanding of the complexity of the host-parasite interactions and impedes the evaluation of therapies for Chagas disease. The present study adopted the CUBIC pipeline to clarify and stain intact organs and tissues of T. cruzi-infected mice.

Multiple tissue clearing protocols were tested in this study (PACT32, ECi33, FLASH34.......

Acknowledgements

We thank Dr. Etsuo Susaki for their valuable help and recommendations regarding tissue-clearing and immunostaining protocols. Also, we are grateful to M. Kandasamy from the CTEGD Biomedical Microscopy Core for technical support using LSFM and confocal imaging. We also thank all the members of Tarleton Research Group for helpful suggestions throughout this study.

....

Materials

NameCompanyCatalog NumberComments
1-methylimidazoleMillipore Sigma616-47-7
2,3-Dimethyl-1-phenyl-5-pyrazolone (AntipyrineTCID1876
6-wells cell culture platesThermoFisher Scientific140675
AlexaFluor 647 anti-mouse Fab fragmentJackson Immuno Research Laboratories315-607-003
AlexaFluor 647 anti-rabbit Fab fragmentJackson Immuno Research Laboratories111-607-003
anti-GFP nanobody Alexa Fluor 647Chromotekgb2AF647-50
anti-RFPRockland600-401-379
anti-α-SMASigmaA5228
B6.C+A2:A44g-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J mouseThe Jackson LaboratoryStrain #007914Common Name: Ai14 , Ai14D or Ai14(RCL-tdT)-D
B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze/J mouseThe Jackson LaboratoryStrain #007914Common Name: Ai14 , Ai14D or Ai14(RCL-tdT)-D
BOBO-1 IodideThermoFisher ScientificB3582
Bovine serum albumin (BSA)Sigma#A7906
C57BL/6J-Tg(Cd8a*-cre)B8Asin/J mouseThe Jackson LaboratoryStrain #032080Common Name: Cd8a-Cre (E8III-Cre)
CAPSOSigma#C2278
Cleaning wipes Kimwipes Kimberly-ClarkT8788
Confocal Laser Scanning MicroscopeZeissLSM 790
CUBIC-HV 1 3D immunostaining kitTCIC3699
CUBIC-HV 1 3D nuclear staining kitTCIC3698
CUBIC-LTCIT3740
CUBIC-PTCIT3782
CUBIC-R+TCIT3741
Cyanoacrylate-based gel superglueScotch571605
DiR (DiIC18(7); 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide) Company: BiotiumBiotium#60017
Ethylene diamine tetra acetic acid (EDTA)Millipore Sigma60-00-4
Falcon Centrifuge tubes 15 mLCorningCLS430791
Falcon Centrifuge tubes 50  mLCorningCLS430290
FormalinSigma-AldrichHT501128
HeparinThermoFisher ScientificJ16920.BBR
HyaluronidaseSigma#H3884 or #H4272
Imaris File Converter x64BitPlanev9.2.0
Imaris softwareBitPlanev9.3
ImSpector softwareLaVision BioTec, Miltenyi Biotecv6.7
Intravenous injection needle 23-GSartori, Minisart Syringe filter16534
Kimwipeslint free wipes
Light-sheet fluorescent microscopeMiltenyi BiotecULtramicroscope II imaging system
MethanolThermoFisher Scientific041838.K2
Micropipette tips, 10 µL, 200 µL and 1,000 µLAxygenT-300, T-200-Y and T-1000-B
Motorized pipet dispenserFisher Scientific, Fisherbrand03-692-172
Mounting SolutionTCIM3294
N-butyldiethanolamineTCIB0725
NicotinamideTCIN0078
N-MethylnicotinamideTCIM0374
Paraformaldehyde (PFA)Sigma-Aldrich158127
Phosphate buffered saline (PBS)Thermo Fisher Scientific14190-094
RedDot 2 Far-Red Nuclear StainBiotium#40061
Sacrifice Perfusion SystemLeica10030-380
ScissorsFine Science Tools91460-11
Serological pipettesCostar Sterile4488
Shaking incubatorTAITECBR-43FM MR
Sodium azide (NaN3)ThermoFisher Scientific447815000
Sodium carbonate (Na2CO3)ThermoFisher ScientificL13098.36
Sodium Chloride (NaCl)ThermoFisher Scientific447302500
Sodium hydrogen carbonate (NaHCO3)ThermoFisher Scientific014707.A9
SYTOX-G Green Nucleic Acid StainThermoFisher ScientificS7020
Triton X-100Sigma-AldrichT8787

References

  1. Schofield, C. J., Jannin, J., Salvatella, R. The future of Chagas disease control. Trends in Parasitology. 22 (12), 583-588 (2006).
  2. Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., Simoes, M. V. Pathogenesis of chronic Chagas heart disease.

Explore More Articles

AI3D ImagingTrypanosoma CruziAmastigotesT CellsChagas DiseaseCUBIC LImmunostainingMicroscopy

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved